Posts

Posted on

Motley Fool Money - NVIDIA Posts Earnings. Wall Street Says “That’s It?”

NVIDIA has been the belle of the quarterly earnings ball for quite some time. Investors have been waiting to see how much NIVIDA beat earnings estimates. Even though earnings did beat expectations, the market reaction was “meh”. The gang breaks down NVIDIA’s earnings and investigates into some of the challenges for the future


Tyler Crowe, Matt Frankel, and Jon Quast discuss:


- NVIDIA’s earnings

- The evolving landscape for CPUs and GPUs

- The bull vs. bear look at MercadoLibre's earnings

- The Trade Desk’s quarterly results


Companies discussed: NVDA, AMD, GOOG, MELI, AMZN, TTD, WMT, ROKU


Host: Tyler Crowe

Guests: Matt Frankel, Jon Quast

Engineer: Dan Boyd


Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement.


We’re committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode.


Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices⁠⁠

Learn more about your ad choices. Visit megaphone.fm/adchoices

Posted on

WSJ Minute Briefing - Nvidia Drags Nasdaq Lower

Plus: Zoom Communications stock falls after missing expectations. And J.M. Smucker shares rally after agreeing to appoint two new positions to its board. Katherine Sullivan hosts.


Sign up for the WSJ's free What's News newsletter.


An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Posted on

State of the World from NPR - The war raging in the Democratic Republic of Congo

It is a war for control over some of the world’s richest mineral reserves and the violence is heightened by long-standing ethnic and political tensions. In the eastern Democratic Republic of Congo, government forces and local militia groups are fighting M23 rebels backed by neighboring Rwanda.

This is one of the wars President Trump repeatedly claims to have ended. But though a U.S.-brokered peace deal was signed, the fighting hasn’t stopped. We go behind the government front lines for a glimpse of the conflict.

To manage podcast ad preferences, review the links below:

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Posted on

The Journal. - How One Company Is Navigating a New Era of Tariff Uncertainty

Newell Brands, the Atlanta-based maker of dozens of household brands including Rubbermaid, Coleman and Yankee Candle, paid more than $170 million in tariffs last year. Newell’s CEO Chris Peterson tells Jessica Mendoza that those tariffs hurt business and the company is considering requesting a refund. He also talks about plans to bring more manufacturing to America. One of its brands, Sharpie, is now almost completely made in the United States. But making that happen wasn’t easy. 

Further Listening: 


Learn more about your ad choices. Visit megaphone.fm/adchoices

Posted on

In the Loop with Sasha-Ann Simons - Is American Citizenship A Myth?

Who gets to be an American citizen? And what rights does citizenship afford? Those questions are explored in the new book, “Citizenship: Notes on an American Myth.” Local author Daisy Hernández blends personal stories with a retrospective on how citizenship was initially constructed and how it’s changed over time. In the Loop sits down with the author to discuss. For a full archive of In the Loop interviews, head over to wbez.org/intheloop.
Posted on

The Bulwark Podcast - Jonathan Chait: The World’s Worst People

No matter how often Trump tries to change the subject, he keeps getting caught in his own attempted diversions. He blames Somali immigrants for importing bribery, corruption, and lawlessness while he sits behind the resolute desk taking a million dollar bribe to bitch about a new bridge. Or he showcases the US men's hockey team while his lying FBI director gets caught red-handed pretending he just happened to be in Italy when the team was playing. And the more Trump tries to run away from the Epstein case, the more blatant the administration's cover-up becomes. Plus, distancing from the craziest parts of the DSA is part of the anti-authoritarian project, Mamdani and AOC have avoided some of their fan base's worst impulses, Newsom put his name on a number of policies that will dog his ambitions, and the Dems need to reclaim improving public schools as one of their key issues.

The Atlantic’s Jon Chait joins Tim Miller.

show notes

Posted on

1A - The Future Of Fertility In 2026

Millions of people struggle to become pregnant in the U.S. And in 2024, fertility rates reached a new low, according to CDC data. Women are also waiting longer to have kids, while a growing number are deciding to opt out entirely.

That’s part of the reason the Trump administration is pushing for a baby boom and promising to make in-vitro fertilization more accessible. Earlier this month, the administration’s new discounted prescription drug website, TrumpRx, went live.

But fertility treatments continue to be prohibitively expensive for many, with the average cumulative cost of IVF treatments reaching up to $60,000. That’s according to FertilityIQ.

Beyond the eye-popping price tag, the journey itself can be emotionally taxing. The stress is so great it’s been compared to a cancer diagnosis and can bring feelings of shame and guilt. It can also be confusing trying to decipher the many doctors’ appointments and medical jargon.

We sit down with an expert panel to talk through the latest in fertility treatments, debunk some persistent myths, and answer your questions.

Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.

To manage podcast ad preferences, review the links below:

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy